RushNet, Inc.: Rushnet's Subsidiary heliosDX Launches Human Monkepox Virus Testing, Available Immediately
ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner
William Hinman Jay Clayton Dx Document Library Division Of Corporation National Clinical Reference Laboratory Rushnet Inc
Source: finanznachrichten.de